about
Structure and coding content of CST (BART) family RNAs of Epstein-Barr virusSignal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from LatencyEpstein-Barr virus and Burkitt lymphomaReactivation of Epstein-Barr virus from latencyApplication of a generalized random effects regression model for cluster-correlated longitudinal data to a school-based smoking prevention trial.Histone acetylation and reactivation of Epstein-Barr virus from latency.Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus.Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA.Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cellsDNA sequence and expression of the B95-8 Epstein-Barr virus genome.Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy.The role of Epstein-Barr virus in cancer.Molecular genetic analysis of Epstein-Barr virus Cp promoter functionRUNX expression and function in human B cells.E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasiaEpstein-Barr virus gene expression in oral hairy leukoplakia.The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle.A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus.Signal transducer and activator of transcription 3 limits Epstein-Barr virus lytic activation in B lymphocytes.RUNX3-mediated repression of RUNX1 in B cells.Homologous upstream sequences near Epstein-Barr virus promoters.Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype.Strain variation in Epstein-Barr virus immediate early genes.Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells.Structure and function of the Epstein-Barr virus BZLF1 protein.Molluscum Contagiosum Virus Protein MC005 Inhibits NF-κB Activation by Targeting NEMO-Regulated IκB Kinase Activation.A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus type 1 EBNA-2.The -1195G allele increases the transcriptional activity of cyclooxygenase-2 gene (COX-2) in colon cancer cell lines.Novel function of the unique N-terminal region of RUNX1c in B cell growth regulation.The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma.Multiple functions within the Epstein-Barr virus EBNA-3A protein.Variant chromatin structure of the oriP region of Epstein-Barr virus and regulation of EBER1 expression by upstream sequences and oriP.Cellular gene expression that correlates with EBER expression in Epstein-Barr Virus-infected lymphoblastoid cell lines.Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death.X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein-Barr virus in co-infected primary effusion lymphoma.Promoter sequences required for reactivation of Epstein-Barr virus from latencyRegulation of the Epstein-Barr virus Zp promoter in B lymphocytes during reactivation from latency.Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferationExpression of cyclin D2 in Epstein-Barr virus-positive Burkitt's lymphoma cell lines is related to methylation status of the gene.Host cell requirements for efficient infection of quiescent primary B lymphocytes by Epstein-Barr virus.
P50
Q24524755-47630D8E-91FB-4607-9838-9D96316C24E2Q24538669-A9D658F1-5BB9-4CB8-B01B-CA3DED512C0EQ24669890-8D64F881-0B00-403B-BEA6-A2ACD3D228A6Q27728174-A32BAA55-12AB-4434-BCDC-E627744161E5Q30621588-B18C69CD-AF64-4EC6-A5A5-C25FB0F523D6Q33796114-AFA015B6-2586-4E0D-A57B-FB9F28A9BD97Q33813615-B8CB2CA9-4A5B-466B-8C08-1523E52F9A60Q33907682-0235FD4D-4756-4108-B9B1-E5288C4C0A3BQ33929593-277DC654-425F-4C0D-8ACA-E8E93FA21FEEQ34245077-DDF39416-A529-4D1D-8F9F-1CBEB52D426FQ34271121-8C0D0F73-5ED8-4EC9-912B-9F3E4C330180Q34574840-C1861BFF-3B58-4D77-B6D3-B3EC216F9CF4Q35856784-508742FA-EA6A-4E2B-B464-FDAE1D04B4A3Q36439233-B7BBB656-504E-4236-88C1-984AE2D59BD0Q36643752-265C84D4-6500-4340-8129-28454C16D1E2Q36771882-87AF764E-FE93-4F28-9681-0B1DE3BDBA2FQ36829427-06EF0E8A-DB13-4C29-8027-7566F56BDBC9Q36919542-B3292E73-B5B4-4891-AFAA-9392A3387DCDQ37252690-F173B917-49D8-43BE-9EB9-E5743831EE36Q37551761-D1A9DC2D-D2BA-41AE-A0B1-041C33F43F90Q37606220-028BC8FC-CA98-46D7-AFC4-367E54AF6337Q38289967-138F08F9-B6FE-448A-A886-D93F64AAAE10Q38322231-E195152C-966A-4271-A93C-44201A1B23A0Q38331064-14AC432F-5E3D-48ED-8FA2-84B5B954322DQ38341018-86E17CDD-D8FA-49CC-8582-049B043AD968Q38704029-8F63F066-4923-4E0C-8132-7B0EF5C79D28Q38992835-8B9FE534-2590-45FA-8A36-CD3C6470327BQ39138209-BD04D138-867B-4ED6-8005-D779E09F08F1Q39223502-7911E34C-3D2D-4529-B63D-93F6399FBAB3Q39284024-80524E92-2DF3-4841-99D1-A83D1EE1C7F3Q39577674-74292860-2CDD-442E-9517-1359556D666AQ39603362-637B052D-08BD-41E8-96AB-C0EF2F0A692FQ39605687-CB674D84-DFD0-4E3F-8103-B5F46C96DDD2Q39605706-AC417305-F809-430B-A2CC-367C5B080E5CQ39639121-24545A1E-7200-4507-A250-BBFDCFBFE744Q39685040-D331704B-9EE4-472F-83E7-3E215FF487D4Q39773143-7542A933-5622-4E88-BFA0-B1A483EC6D5BQ39858777-CA4DFA71-7F82-4BE7-9CAC-BD597A6F7F95Q39868924-1AF98A6F-3FCE-4610-B35B-D48BEED065E7Q39871551-382094BD-383D-46D9-8D35-0BD32B63023A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Paul J Farrell
@ast
Paul J Farrell
@en
Paul J Farrell
@es
Paul J Farrell
@sl
type
label
Paul J Farrell
@ast
Paul J Farrell
@en
Paul J Farrell
@es
Paul J Farrell
@sl
prefLabel
Paul J Farrell
@ast
Paul J Farrell
@en
Paul J Farrell
@es
Paul J Farrell
@sl
P106
P21
P31
P496
0000-0002-6754-9351